Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | General Counsel | September 14, 2026 | September 16, 2026 |
| Outset Medical, Inc.OM · Entity 7026 | General Counsel | August 17, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,000 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 29,000 · Balance 29,000 F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2036-09-13 | Direct | 85,000 |
Reported balance
After 2026-09-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-14 · Grant · Acquired 85,000 · Balance 85,000 F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Outset Medical, Inc.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,475 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 2,632 · Balance 87,475 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2023 Filed Feb 17, 2023 01:35 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,000 | $24.36 | $24,360.00 |
DisclosureSEC source: 0001484612-23-000018 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,422 F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,953 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:35 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 358 | $24.36 | $8,720.88 |
DisclosureSEC source: 0001484612-23-000018 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,422 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 2,265 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · derivative · entry 7 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,265 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,829 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,633 Underlying: Common Stock · 2,829 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,532 | $24.22 | $85,545.04 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,890 Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,829 | $23.96 | $67,770.39 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,422 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 2,829 | $9.48 | $26,818.92 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,265 | $23.96 | $54,259.43 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,422 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 2,265 | $9.48 | $21,472.20 |
DisclosureSEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:42 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,282 | $27.92 | $119,553.44 |
DisclosureSEC source: 0001484612-23-000011 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,780 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,814 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:55 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000007 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,062 F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:55 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 38,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000007 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,878 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,761 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000081 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,462 Underlying: Common Stock · 12,761 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 12,761 | $20.34 | $259,497.49 |
DisclosureSEC source: 0001484612-22-000081 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,044 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 12,761 | $9.48 | $120,974.28 |
DisclosureSEC source: 0001484612-22-000081 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 01:30 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,918 | $19.00 | $36,442.00 |
DisclosureSEC source: 0001484612-22-000079 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,044 Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:29 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 352 | $19.28 | $6,786.56 |
DisclosureSEC source: 0001484612-22-000078 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,962 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 22:14 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 351 | $21.48 | $7,539.48 |
DisclosureSEC source: 0001484612-22-000063 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,314 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 17, 2022 Filed May 17, 2022 22:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 349 | $26.36 | $9,199.64 |
DisclosureSEC source: 0001484612-22-000038 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,665 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 699 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 1,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265 Underlying: Common Stock · 1,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,415 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,223 Underlying: Common Stock · 1,415 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,415 | $43.25 | $61,197.34 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,415 | $9.48 | $13,414.20 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,000 | $43.25 | $43,249.00 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,000 | $9.48 | $9,480.00 |
DisclosureSEC source: 0001484612-22-000034 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 22:53 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,400 | $40.46 | $56,644.00 |
DisclosureSEC source: 0001484612-22-000027 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,014 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 22:53 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,392 | $39.77 | $55,359.84 |
DisclosureSEC source: 0001484612-22-000027 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,414 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,792 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 1,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,265 Underlying: Common Stock · 1,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,586 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,638 Underlying: Common Stock · 5,586 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,586 | $38.59 | $215,555.92 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 - 3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,586 | $9.48 | $52,955.28 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,000 | $38.59 | $38,588.60 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 - 3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,000 | $9.48 | $9,480.00 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:51 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,003 | $43.73 | $43,861.19 |
DisclosureSEC source: 0001484612-22-000020 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,265 Underlying: Common Stock · 3,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,002 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,224 Underlying: Common Stock · 7,002 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 7,002 | $35.92 | $251,490.83 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 7,002 | $9.48 | $66,378.96 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,000 | $35.92 | $107,751.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,000 | $9.48 | $28,440.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:46 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000010 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:46 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 23,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000010 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,990 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265 Underlying: Common Stock · 3,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,002 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,226 Underlying: Common Stock · 7,002 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 7,002 | $35.61 | $249,308.31 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 7,002 | $9.48 | $66,378.96 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,000 | $35.61 | $106,815.90 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,000 | $9.48 | $28,440.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:27 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,500 | $47.05 | $117,625.00 |
DisclosureSEC source: 0001484612-22-000002 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 250 shares; $46.00-$46.99 - 331 shares; $47.00-$47.99 - 1,819 shares; $48.00 - $48.99 - 100 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 21:42 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000089 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,265 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.